Back to Rankings

RCKT

RocketA
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-21
View Chart
+
Peers tracked
11
U.S. public peers
Grade Position
Above peers
vs peer average
RCKT vs peer average
85/100
RCKT vs. peer average (A vs. C)
Grade spread
A 1 · B 3 · C 2 · D 3 · F 2
Graded peers loaded
Coverage
11 graded
100% of tracked

Peer overview

VOR is the first available peer comparator.

Loose small-cap gene/cell therapy peer with binary clinical and financing risk; useful for event-volatility framing, but not a direct indication match.

Peer source comes from the stored AI memo or peer model
Grades and factor rows use RankAlpha API data when available
Missing peer scores remain blank instead of being estimated
Side-by-side comparison keeps the data contract visible
Top peerVORVor Biopharma
RCKT
Rocket
VOR
Vor Biopharma
Grade
A
D
Momentum
74
92
Value
41
41
Sentiment
82
24
Setup Bias
Net —
-
Market Cap
-
-
Posture
Constructive
Defensive

Grade position vs VOR

RCKT / VOR
Grade Position
Above peers
RCKT vs. peer average (A vs. C)
85/100
Momentum
74
VOR
Value
41
RCKT
Sentiment
82
RCKT

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs RCKT
1
VOR
VOR
C
60/100
+2
2
TECX
TECX
D
40/100
+3
3
EPRX
EPRX
B
80/100
+1
4
STRO
Sutro Biopharma Inc Common
D
40/100
+3
5
AUTL
Autolus Therapeutics Plc ADR
A
100/100
Even
VOR is the first peer returned for this comparison set.